A record of what Sumeet Bagadia said publicly, with the source. Not advice.
“Bullish on Supriya Lifescience, recommending a buy at ₹788 with a target of ₹850 and a stop loss at ₹760. This is part of a stock-specific approach focusing on breakout stocks for intraday trading, given the broader market's cautious to positive sentiment.”
Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
Entry: ₹788, as stated.
Target ₹850, stop ₹760, as stated.
Window: 30 days, the time frame the call states ("intraday").
The stop ₹760 was reached on a close before the target ₹850. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹788 on 2025-04-04 (stated entry ₹788, LEVEL_CMP entry, filled); stop ₹760 breached at close ₹709.65 on 2025-04-04. Window 30 days — rule H1: the quote says "intraday" (a one-day claim, judged over 30 days; MISS if neither level is reached).